SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-029665
Filing Date
2011-05-16
Accepted
2011-05-16 13:05:01
Documents
1
Period of Report
2011-05-02

Document Format Files

Seq Description Document Type Size
1 form441446_051611130435-.html 4  
1 form441446_051611130435-.xml 4 6449
  Complete submission text file 0001144204-11-029665.txt   7794
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUCAMPO PHARMACEUTICALS 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address
Dolecek Gayle R (Reporting) CIK: 0001383377 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 11845015